CMap Candidates
CMap (Connectivity Map) candidates are extracted from CLUE (CMap and LINCS Unified Environment), with detailed information, e.g., perturbagen time and dose, compound structure, targets, SMILES, mechanism of action. Two publicly available gene expression profiles of NAFLD are used to calculate individual connectivity scores and corresponding statistical significances for these candidates.
stats1
stats2
34330 records.
CMap ID | Pert ID | Compound Name | Targets | MoA | Compound Aliases | |
---|---|---|---|---|---|---|
C18704 | BRD-K51126930 | BRD-K51126930 | -- | -- | jpu-E_100001-4 | Details |
C18705 | BRD-K51131084 | BRD-K51131084 | -- | -- | -- | Details |
C18706 | BRD-K51133104 | BRD-K51133104 | -- | -- | -- | Details |
C18707 | BRD-K51134784 | BRD-K51134784 | -- | -- | -- | Details |
C18708 | BRD-K51140037 | BRD-K51140037 | -- | -- | -- | Details |
C18709 | BRD-K51140856 | BRD-K51140856 | -- | -- | -- | Details |
C18710 | BRD-K51141297 | BRD-K51141297 | -- | -- | -- | Details |
C18711 | BRD-K51143622 | BRD-K51143622 | -- | -- | -- | Details |
C18712 | BRD-K51143828 | lurasidone | HTR2A; HTR7; ADRA2A; ADRA2C; DRD2; HTR1A | Serotonin receptor antagonist; Dopamine receptor antagonist | -- | Details |
C18713 | BRD-K51147043 | BRD-K51147043 | -- | -- | -- | Details |
C18714 | BRD-K51147721 | BRD-K51147721 | -- | -- | -- | Details |
C18715 | BRD-K51153795 | BRD-K51153795 | -- | -- | -- | Details |
C18716 | BRD-K51155404 | BRD-K51155404 | -- | -- | -- | Details |
C18717 | BRD-K51157416 | BRD-K51157416 | -- | -- | -- | Details |
C18718 | BRD-K51160592 | BRD-K51160592 | -- | -- | -- | Details |
C18719 | BRD-K51163606 | BRD-K51163606 | -- | -- | -- | Details |
C18720 | BRD-K51164721 | BRD-K51164721 | -- | -- | -- | Details |
C18721 | BRD-K51166678 | BRD-K51166678 | -- | -- | -- | Details |
C18722 | BRD-K51167279 | BRD-K51167279 | -- | -- | -- | Details |
C18723 | BRD-K51169491 | BRD-K51169491 | -- | -- | -- | Details |
C18724 | BRD-K51175229 | BRD-K51175229 | -- | -- | -- | Details |
C18725 | BRD-K51179640 | BRD-K51179640 | -- | -- | -- | Details |
C18726 | BRD-K51181201 | BRD-K51181201 | -- | -- | -- | Details |
C18727 | BRD-K51181663 | BRD-K51181663 | -- | -- | -- | Details |
C18728 | BRD-K51185182 | BRD-K51185182 | -- | -- | -- | Details |
C18729 | BRD-K51186655 | BRD-K51186655 | -- | -- | -- | Details |
C18730 | BRD-K51189903 | BRD-K51189903 | -- | -- | -- | Details |
C18731 | BRD-K51196703 | BRD-K51196703 | -- | -- | -- | Details |
C18732 | BRD-K51197994 | BRD-K51197994 | -- | -- | -- | Details |
C18733 | BRD-K51201721 | BRD-K51201721 | -- | -- | -- | Details |
C18734 | BRD-K51202492 | BRD-K51202492 | -- | -- | -- | Details |
C18735 | BRD-K51207550 | ethionamide | -- | -- | -- | Details |
C18736 | BRD-K51207618 | BRD-K51207618 | -- | -- | -- | Details |
C18737 | BRD-K51215422 | BRD-K51215422 | -- | -- | -- | Details |
C18738 | BRD-K51216807 | BRD-K51216807 | -- | -- | -- | Details |
C18739 | BRD-K51217456 | BRD-K51217456 | -- | -- | -- | Details |
C18740 | BRD-K51218228 | BRD-K51218228 | -- | -- | -- | Details |
C18741 | BRD-K51220638 | BRD-K51220638 | -- | -- | -- | Details |
C18742 | BRD-K51223576 | AG-99 | -- | -- | -- | Details |
C18743 | BRD-K51228600 | BRD-K51228600 | -- | -- | -- | Details |
C18744 | BRD-K51234905 | BRD-K51234905 | -- | -- | -- | Details |
C18745 | BRD-K51237366 | SA-1938867 | -- | -- | -- | Details |
C18746 | BRD-K51237617 | BRD-K51237617 | -- | -- | -- | Details |
C18747 | BRD-K51241952 | BRD-K51241952 | -- | -- | -- | Details |
C18748 | BRD-K51247865 | BRD-K51247865 | -- | -- | ipragliflozin-l-proline | Details |
C18749 | BRD-K51252203 | BRD-K51252203 | -- | -- | -- | Details |
C18750 | BRD-K51253991 | BRD-K51253991 | -- | -- | -- | Details |
C18751 | BRD-K51256476 | BRD-K51256476 | -- | -- | -- | Details |
C18752 | BRD-K51257364 | BRD-K51257364 | -- | -- | -- | Details |
C18753 | BRD-K51263939 | sarcosine | SLC6A9 | Glycine transporter inhibitor | -- | Details |
C18754 | BRD-K51266459 | BRD-K51266459 | -- | -- | -- | Details |
C18755 | BRD-K51267267 | BRD-K51267267 | -- | -- | -- | Details |
C18756 | BRD-K51270604 | BRD-K51270604 | -- | -- | -- | Details |
C18757 | BRD-K51272331 | BRD-K51272331 | -- | -- | -- | Details |
C18758 | BRD-K51275565 | BRD-K51275565 | -- | -- | -- | Details |
C18759 | BRD-K51276371 | aloisine | CDK2 | CDK inhibitor; GSK-3 inhibitor; CFTR channel agonist | -- | Details |
C18760 | BRD-K51278788 | BRD-K51278788 | -- | -- | -- | Details |
C18761 | BRD-K51281570 | BRD-K51281570 | -- | -- | -- | Details |
C18762 | BRD-K51285422 | BRD-K51285422 | -- | -- | -- | Details |
C18763 | BRD-K51287451 | BRD-K51287451 | -- | -- | -- | Details |
C18764 | BRD-K51288770 | BRD-K51288770 | -- | -- | -- | Details |
C18765 | BRD-K51290057 | SA-792709 | RARA; RARB | Retinoid receptor agonist | -- | Details |
C18766 | BRD-K51295743 | BRD-K51295743 | -- | -- | -- | Details |
C18767 | BRD-K51296348 | BRD-K51296348 | -- | -- | -- | Details |
C18768 | BRD-K51298794 | BRD-K51298794 | -- | -- | -- | Details |
C18769 | BRD-K51302260 | KU-C103871 | SMAD3 | GSP agonist | -- | Details |
C18770 | BRD-K51313569 | palbociclib | CDK4; CDK6 | CDK inhibitor | -- | Details |
C18771 | BRD-K51318897 | fenbendazole | TUBB | Tubulin inhibitor | -- | Details |
C18772 | BRD-K51320264 | BRD-K51320264 | -- | -- | -- | Details |
C18773 | BRD-K51320582 | BRD-K51320582 | -- | -- | -- | Details |
C18774 | BRD-K51322285 | BRD-K51322285 | -- | -- | -- | Details |
C18775 | BRD-K51322795 | BRD-K51322795 | -- | -- | -- | Details |
C18776 | BRD-K51323894 | BRD-K51323894 | -- | -- | -- | Details |
C18777 | BRD-K51324732 | meglitinide | -- | -- | -- | Details |
C18778 | BRD-K51328581 | BRD-K51328581 | -- | -- | -- | Details |
C18779 | BRD-K51329831 | BRD-K51329831 | -- | -- | -- | Details |
C18780 | BRD-K51333959 | siramesine | -- | -- | -- | Details |
C18781 | BRD-K51335814 | BRD-K51335814 | -- | -- | -- | Details |
C18782 | BRD-K51338042 | BRD-K51338042 | -- | -- | -- | Details |
C18783 | BRD-K51339020 | BRD-K51339020 | -- | -- | -- | Details |
C18784 | BRD-K51342021 | BRD-K51342021 | -- | -- | -- | Details |
C18785 | BRD-K51348184 | BRD-K51348184 | -- | -- | -- | Details |
C18786 | BRD-K51349050 | BRD-K51349050 | -- | -- | -- | Details |
C18787 | BRD-K51350053 | toremifene | ESR1 | Estrogen receptor antagonist; Selective estrogen receptor modulator | -- | Details |
C18788 | BRD-K51350137 | SA-90377 | -- | -- | -- | Details |
C18789 | BRD-K51358551 | BRD-K51358551 | -- | -- | -- | Details |
C18790 | BRD-K51360326 | BRD-K51360326 | -- | -- | -- | Details |
C18791 | BRD-K51361049 | BRD-K51361049 | -- | -- | -- | Details |
C18792 | BRD-K51363316 | BRD-K51363316 | -- | -- | -- | Details |
C18793 | BRD-K51363657 | SA-1457769 | -- | -- | -- | Details |
C18794 | BRD-K51364219 | BRD-K51364219 | -- | -- | -- | Details |
C18795 | BRD-K51365808 | BRD-K51365808 | -- | -- | -- | Details |
C18796 | BRD-K51368089 | BRD-K51368089 | -- | -- | -- | Details |
C18797 | BRD-K51368944 | BRD-K51368944 | -- | -- | -- | Details |
C18798 | BRD-K51370144 | BRD-K51370144 | -- | -- | -- | Details |
C18799 | BRD-K51372689 | BRD-K51372689 | -- | -- | -- | Details |
C18800 | BRD-K51377689 | BRD-K51377689 | -- | -- | -- | Details |
C18801 | BRD-K51381937 | BRD-K51381937 | -- | -- | -- | Details |
C18802 | BRD-K51385533 | BRD-K51385533 | -- | -- | -- | Details |
C18803 | BRD-K51388814 | BRD-K51388814 | -- | -- | -- | Details |